Recombinant Gazella spekei Cytochrome c oxidase subunit 2 (MT-CO2) is a protein produced through recombinant DNA technology. This protein is a component of the cytochrome c oxidase complex, which plays a crucial role in the electron transport chain of mitochondria. The cytochrome c oxidase complex is responsible for the final step of oxidative phosphorylation, where oxygen is reduced to water, and ATP is produced. The MT-CO2 subunit is specifically encoded by the mitochondrial genome and is essential for the proper functioning of the enzyme.
The recombinant Gazella spekei Cytochrome c oxidase subunit 2 (MT-CO2) is produced using an in vitro E. coli expression system. This method allows for high purity and yield of the protein, making it suitable for various research applications. The use of E. coli as a host organism is common due to its well-understood genetics and ease of manipulation.
| Characteristics | Description |
|---|---|
| Host Organism | E. coli |
| Expression System | In vitro |
| Purity | High |
| Application | Research |
Cytochrome c oxidase is a key enzyme in the mitochondrial electron transport chain, facilitating the transfer of electrons from cytochrome c to oxygen, resulting in the production of ATP. The MT-CO2 subunit is crucial for maintaining the structural integrity and function of this enzyme complex. Alterations or mutations in this subunit can lead to mitochondrial dysfunction, which is associated with various diseases.
The recombinant Gazella spekei Cytochrome c oxidase subunit 2 (MT-CO2) can be used in various research contexts, including studies on mitochondrial function, disease modeling, and the development of therapeutic interventions targeting mitochondrial disorders.
| Application Area | Description |
|---|---|
| Mitochondrial Studies | Investigating electron transport chain dynamics |
| Disease Modeling | Understanding mitochondrial dysfunction in diseases |
| Therapeutic Development | Developing treatments for mitochondrial-related disorders |
Cytochrome c oxidase subunit 2 (MT-CO2) is a component of cytochrome c oxidase (Complex IV), the terminal enzyme in the mitochondrial electron transport chain (ETC). This chain, consisting of three multi-subunit complexes (Complex II, Complex III, and Complex IV), facilitates oxidative phosphorylation. Complex IV catalyzes the reduction of oxygen to water, utilizing electrons from reduced cytochrome c in the intermembrane space (IMS). These electrons are transferred via the CuA center of subunit 2 and heme A of subunit 1 to the binuclear center (BNC) in subunit 1, composed of heme A3 and CuB. The BNC reduces molecular oxygen to water, using four electrons from cytochrome c and four protons from the mitochondrial matrix, thereby generating the proton gradient essential for ATP synthesis.
Gazella spekei Cytochrome c oxidase subunit 2 (MT-CO2) is a transmembrane protein component of Complex IV in the mitochondrial respiratory chain. It contains 227 amino acids with the sequence: MAYPMQLGFQDATSPIMEELLHFHDHTLMIVFLISSLVLYVISLMLTTKLTHTST MDAQE VETIWTILPAIILILIALPSLRILYMMDEINNPSLTVKTMGHQWYWSYEYTDYEDLSFDS YMIPTSELKPGELRLLEVDNRVVLPMEMTIRMLISSEDVLHSWAVPSLGLKTDAI PGRLN QTTLMSARPGLYYGQCSEICGSNHSFMPIVLELVPLKYFEKWSASML .
Functionally, Cytochrome c oxidase subunit 2 plays a vital role in cellular respiration by receiving electrons from cytochrome c and transferring them to the cytochrome a3-CuB binuclear center. As part of the larger Complex IV, it contributes to oxygen reduction and proton transport across the mitochondrial membrane, which is essential for ATP synthesis .
The metabolic profile of Gazella spekei shows uniquely high resting metabolic rates (RMR) compared to other gazelle species. With an RMR of 432 ± 32 kJ kg BM^-0.75 d^-1, G. spekei demonstrates approximately 47% higher metabolic rate than would be predicted by standard models (Kleiber ratio: 1.47 ± 0.11) . This elevated metabolic activity correlates with respiratory chain function, where cytochrome c oxidase plays a crucial role.
Notably, G. spekei has the lowest respiratory quotient (RQ = 0.76 ± 0.02) among compared gazelle species, indicating a greater reliance on fat metabolism over carbohydrates . This metabolic adaptation may reflect evolutionary pressure in its arid native habitat and potentially affects the regulation of cytochrome c oxidase activity in mitochondrial respiration.
When comparing Gazella spekei MT-CO2 with other gazelle species, several notable differences emerge in both sequence conservation and physiological context:
| Parameter | G. spekei | G. gazella | N. soemmerringii |
|---|---|---|---|
| Body mass (kg) | 12.4 ± 1.3 | 16.3 ± 1.4 | 35.1 ± 4.7 |
| RMR (kJ kg BM^-0.75 d^-1) | 432 ± 32 | 371 ± 31 | 310 ± 32 |
| RMR/BMR ratio (Kleiber) | 1.47 ± 0.11 | 1.27 ± 0.11 | 1.06 ± 0.11 |
| Respiratory Quotient | 0.76 ± 0.02 | 0.77 ± 0.05 | 0.82 ± 0.03 |
These physiological differences suggest potential adaptive variations in MT-CO2 function or regulation across gazelle species . While complete comparative sequence analysis is not provided in the available data, the elevated metabolic rate in G. spekei correlates with its adaptation to its ecological niche and may reflect differences in electron transport chain efficiency.
For optimal storage and handling of Recombinant Gazella spekei MT-CO2:
Store the protein at -20°C for routine storage
For extended storage stability, maintain at -80°C
Avoid repeated freeze-thaw cycles as they significantly reduce protein activity
Working aliquots may be stored at 4°C for up to one week
The shelf life in liquid form is typically 6 months at -20°C/-80°C
Lyophilized preparations maintain stability for approximately 12 months at -20°C/-80°C
When designing experiments, consider preparing single-use aliquots during initial thawing to maintain protein integrity throughout the research timeline. Buffer composition should be verified as compatible with downstream applications, as the standard storage buffer contains Tris-based components with 50% glycerol .
Designing effective expression systems for Recombinant Gazella spekei MT-CO2 requires careful consideration of several factors:
Expression Vector Selection: The commercially available protein utilizes an E. coli expression system with an N-terminal 10xHis-tag . This approach balances yield with proper protein folding.
Codon Optimization: As G. spekei is not a model organism, codon optimization for the expression host is critical. The full-length protein (227 amino acids) may contain rare codons that require optimization.
Tag Placement Considerations: The N-terminal His-tag configuration minimizes interference with the transmembrane domains. Alternative tagging strategies should avoid disrupting the protein's functional domains.
Expression Conditions: Transmembrane proteins often require specialized expression conditions. Lowering induction temperature (16-20°C) and using milder inducers can improve proper folding.
Verification Methods: Confirm successful expression using Western blotting with anti-His antibodies and verify structural integrity through circular dichroism spectroscopy.
For researchers developing their own expression systems, it's advisable to compare results with the commercially available standard (CSB-CF015073GBB) to validate their methods .
When designing experiments to study MT-CO2 activity in comparative physiology:
Metabolic Rate Measurements: Use respirometry chambers equipped with O₂/CO₂ analyzers as employed in gazelle species studies. Ensure adequate acclimation periods (minimum 1 hour) before recording data to minimize stress effects .
Environmental Controls: Standardize temperature, humidity, and light conditions across species comparisons. Gazelles show temporal fluctuations in O₂ consumption with decreases toward night's end .
Normalization Approaches: Express metabolic data per unit metabolic body mass (BM^-0.75) for valid cross-species comparisons. This allows proper contextualization of MT-CO2 function across body size differences .
Diet Standardization: Provide consistent nutrition (e.g., lucerne ad libitum) during experimental periods to control for dietary influences on respiratory quotient.
Data Collection Duration: Record measurements over complete diurnal cycles (minimum 24 hours) to capture the full range of metabolic variability.
For isolation of mitochondria and direct measurement of cytochrome c oxidase activity, tissues should be processed immediately after collection, with activity assays performed at physiologically relevant temperatures specific to the species being studied.
Recombinant Gazella spekei MT-CO2 offers several valuable applications in evolutionary biology research:
Molecular Clock Analyses: MT-CO2, being mitochondrially encoded, evolves at a relatively consistent rate. Researchers can use sequence data to estimate divergence times between Gazella species and other bovids. The full-length sequence (amino acids 1-227) provides sufficient data points for robust phylogenetic analyses .
Adaptive Evolution Studies: The elevated metabolic rate of G. spekei (47% higher than predicted by Kleiber's law) suggests positive selection on respiratory chain components. Researchers can employ Ka/Ks ratio analyses to identify positively selected sites in MT-CO2 that may contribute to this metabolic adaptation.
Structure-Function Relationship: Using the recombinant protein with site-directed mutagenesis, researchers can investigate how specific amino acid changes influence electron transfer efficiency. This approach can reveal the molecular basis for metabolic adaptations in arid-adapted gazelle species.
Comparative Functional Assays: By comparing the kinetic properties of MT-CO2 across gazelle species (G. spekei, G. gazella, N. soemmerringii), researchers can correlate functional differences with the documented metabolic variations (RMR/BMR ratios of 1.47, 1.27, and 1.06 respectively) .
These applications can provide insights into how selection pressures in different ecological niches drive the evolution of energy metabolism at the molecular level.
Investigating the relationship between MT-CO2 structure and metabolic adaptation requires an integrated approach:
Structural Biology Methods:
X-ray crystallography or cryo-EM to determine the three-dimensional structure of G. spekei MT-CO2
Molecular dynamics simulations to model protein-protein interactions within Complex IV
Hydrogen-deuterium exchange mass spectrometry to identify dynamic regions potentially involved in adaptive functions
Functional Assays:
Oxygen consumption measurements using recombinant proteins in reconstituted systems
Electron transfer kinetics compared across species with varying metabolic rates
Proton pumping efficiency measurements to correlate structure with bioenergetic output
Integrative Analysis:
Correlation of specific structural features with metabolic parameters (e.g., RMR values of 432 ± 32, 371 ± 31, and 310 ± 32 kJ kg BM^-0.75 d^-1 for G. spekei, G. gazella, and N. soemmerringii respectively)
Computational modeling of electron flow through mutant variants to predict adaptive advantages
Ecological Context Integration:
Connect molecular findings with ecological parameters (temperature, aridity, food availability)
Correlate structural adaptations with behavioral energy conservation strategies
This multidisciplinary approach allows researchers to establish causative relationships between specific amino acid variants in MT-CO2 and the observed metabolic phenotypes across gazelle species.
Examining post-translational modifications (PTMs) of Gazella spekei MT-CO2 requires a systematic experimental design:
PTM Identification Strategy:
High-resolution mass spectrometry (MS) using multiple fragmentation techniques (CID, ETD, HCD)
Enrichment approaches for specific modifications (phosphopeptide enrichment, glycopeptide capture)
Targeted MS/MS analysis focusing on the conserved histidine-tyrosine cross-link (equivalent to bovine His-240/Tyr-244)
Comparative PTM Analysis:
Functional Significance Assessment:
Site-directed mutagenesis of potential PTM sites
Activity assays comparing wild-type and mutant proteins
Structural analysis to determine how PTMs affect protein conformation and interaction surfaces
Physiological Context Experiments:
Investigate how environmental factors (temperature, pH, oxidative stress) affect PTM patterns
Correlate changes in PTM state with functional parameters like oxygen affinity or electron transfer rates
Researchers should be aware that the recombinant protein expressed in E. coli may lack mammalian-specific PTMs, necessitating comparison with native protein for comprehensive PTM analysis.
Researchers commonly encounter several challenges when working with Recombinant Gazella spekei MT-CO2:
Protein Aggregation Issues:
Activity Loss During Storage:
Inconsistent Experimental Results:
Recombinant vs. Native Protein Differences:
Challenge: E. coli-expressed protein may lack post-translational modifications found in native MT-CO2.
Solution: Compare key functional parameters with native protein when possible; acknowledge limitations in results interpretation.
Electron Transfer Measurement Difficulties:
Challenge: Complex kinetics of electron transfer are difficult to measure accurately.
Solution: Use stopped-flow spectroscopy with defined electron donors; calibrate systems with well-characterized cytochrome c oxidase preparations.
Maintaining detailed experimental records of protein batch, storage duration, and handling conditions can help identify sources of variability in research outcomes.
When interpreting metabolic data in relation to MT-CO2 function across gazelle species, researchers should consider several key factors:
Scaling Relationships and Allometry:
Metabolic rates should be normalized to metabolic body mass (BM^-0.75) to account for size differences between species (G. spekei: 12.4kg; G. gazella: 16.3kg; N. soemmerringii: 35.1kg) .
Use both standard scaling equations (Kleiber and McNab) to calculate expected values versus observed measurements.
Respiratory Quotient (RQ) Interpretation:
Environmental Adaptation Context:
Temporal Variation Assessment:
Statistical Approach:
When directly connecting metabolic parameters to MT-CO2 function, researchers should establish clear mechanistic links rather than assuming correlation implies causation.
To ensure the authenticity and activity of Recombinant Gazella spekei MT-CO2, researchers should implement a comprehensive validation strategy:
Structural Validation:
Sequence Verification: Confirm the expressed protein matches the expected sequence (MAYPMQLGFQDATSPIMEELLHFHDHTLMIVFLISSLVLYVISLMLTTKLTHTST MDAQE VETIWTILPAIILILIALPSLRILYMMDEINNPSLTVKTMGHQWYWSYEYTDYEDLSFDS YMIPTSELKPGELRLLEVDNRVVLPMEMTIRMLISSEDVLHSWAVPSLGLKTDAI PGRLN QTTLMSARPGLYYGQCSEICGSNHSFMPIVLELVPLKYFEKWSASML) using mass spectrometry .
Size Confirmation: Verify molecular weight by SDS-PAGE and western blotting with anti-His antibodies to detect the N-terminal 10xHis tag .
Folding Assessment: Employ circular dichroism spectroscopy to confirm secondary structure elements characteristic of cytochrome c oxidase subunit 2.
Functional Validation:
Electron Transfer Activity: Measure the rate of electron transfer from reduced cytochrome c using spectrophotometric assays.
Oxygen Consumption: Quantify oxygen reduction rates in reconstituted systems or membrane preparations.
Copper Content Analysis: Verify the presence of copper cofactors essential for MT-CO2 function using atomic absorption spectroscopy or inductively coupled plasma mass spectrometry.
Comparative Benchmarking:
Compare activity metrics with other commercially available cytochrome c oxidase preparations.
Establish relative activity compared to native protein from G. spekei tissue when available.
Develop specific activity measurements (activity units per mg protein) as quality control benchmarks.
Stability Assessment:
Monitor activity retention over time under different storage conditions.
Evaluate thermal stability using differential scanning fluorimetry.
Determine pH stability profile to inform buffer selection for downstream applications.
These validation approaches provide a robust framework to ensure that experimental outcomes truly reflect the biological properties of Gazella spekei MT-CO2 rather than artifacts of recombinant expression or storage conditions.
Several cutting-edge technologies show promise for advancing our understanding of Gazella spekei MT-CO2:
Cryo-Electron Microscopy (Cryo-EM):
Enables visualization of MT-CO2 within the entire Complex IV assembly at near-atomic resolution
Allows study of conformational changes during the catalytic cycle without crystallization constraints
Particularly valuable for membrane proteins like MT-CO2 that are challenging to crystallize
AlphaFold2 and Deep Learning Approaches:
Accurate prediction of protein structures can complement experimental data
Allows modeling of species-specific variations in MT-CO2 structure even without direct crystallographic data
Facilitates in silico mutagenesis studies to predict functional consequences of amino acid substitutions
Single-Molecule Techniques:
Single-molecule FRET to track conformational changes during electron transfer
Optical tweezers combined with electrical recordings to correlate mechanical changes with proton pumping
These approaches can reveal heterogeneity in molecular behavior masked in ensemble measurements
In-cell Structural Biology:
NMR and EPR techniques adapted for in-cell measurements
Provides structural information in the native cellular environment
Can reveal physiologically relevant protein-protein interactions
Multi-omics Integration:
Integrating these technologies will provide unprecedented insights into how the unique properties of G. spekei MT-CO2 contribute to its distinctive metabolic profile.
Climate change poses significant challenges to the metabolic adaptations reflected in Gazella spekei MT-CO2 function:
Temperature Adaptation Mechanisms:
G. spekei's elevated metabolic rate (RMR/BMR ratio of 1.47 ± 0.11) may represent an adaptation to its current climate niche
Rising temperatures could shift the optimal efficiency range of MT-CO2 electron transfer
Research should investigate temperature-dependent kinetics of the recombinant protein under projected climate scenarios
Water Conservation and Metabolic Function:
The low respiratory quotient (RQ = 0.76 ± 0.02) of G. spekei indicates fat metabolism preference
Increased aridity may further constrain water availability, potentially selecting for even more efficient MT-CO2 variants
Experimental designs should examine how dehydration affects MT-CO2 activity in tissue samples
Food Resource Alterations:
Changing plant communities will affect nutrient availability and quality
Substrate availability influences electron transport chain function
Metabolic chamber studies with varying nutrient compositions can model these effects
Population Genetic Implications:
Climate-driven range contractions may reduce genetic diversity in MT-CO2 variants
Decreased adaptive potential could limit response to changing conditions
Conservation genetics approaches should monitor MT-CO2 sequence diversity in wild populations
These research directions can provide critical insights for conservation planning while advancing our fundamental understanding of metabolic adaptation mechanisms at the molecular level in changing environments.
Maximizing the research value of Recombinant Gazella spekei MT-CO2 requires innovative interdisciplinary approaches:
Evolutionary Physiology Integration:
Combine molecular evolution analyses with physiological measurements
Map sequence variations to metabolic phenotypes across multiple gazelle species
Correlate selection signatures with ecological parameters in G. spekei's habitat
Bioengineering Applications:
Computational Biology and Machine Learning:
Develop predictive models of protein function based on sequence data
Use machine learning to identify subtle patterns in electron transfer efficiency
Create virtual screening platforms to identify molecules that modulate MT-CO2 activity
Conservation Genomics Connections:
Link MT-CO2 genetic diversity to population viability in endangered gazelle species
Develop MT-CO2 haplotype markers for monitoring wild populations
Use functional genomics to assess adaptive potential under climate change
Comparative Medicine Applications:
Investigate how G. spekei's efficient MT-CO2 might inform research on human mitochondrial disorders
Explore therapeutic relevance of specific structural features for conditions involving cytochrome c oxidase deficiency
Develop experimental models incorporating G. spekei MT-CO2 variants to test therapies
By bridging these diverse disciplines, researchers can extract maximum scientific value from studies of this specialized protein while contributing to both basic science knowledge and applied solutions to contemporary challenges.